A newly published study in The Lancet has provided some very interesting data on the accuracy of a new, multi-biomarker test in screening 50- to 69-year-old men for risk of prostate cancer. The new paper by Grönberg et al. describes the initial results of the so-called Stockholm 3 or STHLM3 study of the ability of […]![]()
